Alternative mRNA splicing in cancer immunotherapy
L Frankiw, D Baltimore, G Li - Nature Reviews Immunology, 2019 - nature.com
Immunotherapies are yielding effective treatments for several previously untreatable
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …
Alternative mRNA splicing in cancer immunotherapy.
L Frankiw, D Baltimore, G Li - Nature Reviews Immunology, 2019 - go.gale.com
Immunotherapies are yielding effective treatments for several previously untreatable
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …
Alternative mRNA splicing in cancer immunotherapy
L Frankiw, D Baltimore, G Li - authors.library.caltech.edu
Immunotherapies are yielding effective treatments for several previously untreatable
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …
Alternative mRNA splicing in cancer immunotherapy
L Frankiw, D Baltimore, G Li - Nature reviews. Immunology, 2019 - pubmed.ncbi.nlm.nih.gov
Immunotherapies are yielding effective treatments for several previously untreatable
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …
[引用][C] Alternative mRNA splicing in cancer immunotherapy
L Frankiw, D Baltimore, G Li - Nature Reviews Immunology, 2019 - cir.nii.ac.jp
Alternative mRNA splicing in cancer immunotherapy.
L Frankiw, D Baltimore, G Li - Nature reviews. Immunology, 2019 - europepmc.org
Immunotherapies are yielding effective treatments for several previously untreatable
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …
cancers. Still, the identification of suitable antigens specific to the tumour that can be targets …